Role of mitophagy in ocular neurodegeneration
Our research points to a decline in consumption across food and beverage categories, but a more pronounced reduction in sugary drinks, confectionery, baked goods and salty snacks
La locura en Espaa por las 'inyecciones milagro' contra la obesidad deja sin frmacos a los diabticos La Aemps ha emitido unas recomendaciones para evitar que el suministro de algunos anlogos del GLP-1 para la diabetes se vea interrumpido
The highest representation of Hispanic participants was in trials supported by the National Institute on Drug Abuse (greater than 16 percent on average)
Tirzepatide deep-dive Tirzepatide is made by Eli Lilly under two brand names: Mounjaro -- weekly injection, FDA-approved for type 2 diabetes in 2022 (doses 2.5 mg through 15 mg) Zepbound -- weekly injection, FDA-approved for chronic weight management in November 2023 [4] The headline trial is SURMOUNT-1: 2,539 adults without diabetes, BMI of 30 or higher (or 27 with a weight-related condition), randomized across three tirzepatide doses (5, 10, 15 mg) versus placebo for 72 weeks